Patent Applications published on Mar 24, 2022 - page 4

#901
US20220087990A1
Human necessities

APPLICATION OF RIFAMYCIN-QUINOLIZIDONE CONJUGATE MOLECULE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF

#902 ✅ Patent 12,150,937 granted on 2024-11-26
US20220087991A1
Human necessities

NLRP3 modulators

#903 ✅ Patent 11,744,826 granted on 2023-09-05
US20220087992A1
Human necessities

Compounds and methods of treating retinal degeneration

#904
US20220087993A1
Human necessities

USE OF MIGALOSTAT IN REDUCING THE RISK OF CEREBROVASCULAR EVENT IN PATIENTS WITH FABRY DISEASE

#905
US20220087994A1
Human necessities

HIGH LOAD DISPERSIONS AND USES THEREOF

#906 ✅ Patent 11,723,900 granted on 2023-08-15
US20220087995A1
Human necessities

4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds

#907
US20220087996A1
Human necessities

Histone acetylase p300 inhibitor and use thereof

#908
US20220087997A1
Human necessities

Oral Antagonist Compositions For Nicotine Burning Relief

#909 ✅ Patent 12,274,695 granted on 2025-04-15
US20220087998A1
Human necessities

Pharmaceutical drug therapy for autism

#910
US20220087999A1
Human necessities

C-Met Modulator Pharmaceutical Compositions

#911
US20220088000A1
Human necessities

COMBINATION THERAPY

#912 ✅ Patent 12,318,377 granted on 2025-06-03
US20220088001A1
Human necessities

Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being

#913
US20220088002A1
Human necessities

METHOD AGAINST CORONAVIRUS INFECTION WITH QUINOLINE COMPOUND

#914 ✅ Patent 11,478,466 granted on 2022-10-25
US20220088003A1
Human necessities

Small molecule promoting osteoblast differentiation

#915
US20220088004A1
Human necessities

COMPOSITION FOR COMPETITIVE INHIBITION OF OREXIN RECEPTORS

#916 ✅ Patent 11,801,243 granted on 2023-10-31
US20220088005A1
Human necessities

Bromodomain inhibitors for androgen receptor-driven cancers

#917
US20220088006A1
Human necessities

ANALOGS OF DEUTETRABENAZINE, THEIR PREPARATION AND USE

#918
US20220088007A1
Human necessities

Increasing Drug Bioavailability In Naltrexone Therapy

#919 ✅ Patent 11,679,108 granted on 2023-06-20
US20220088008A1
Human necessities

Aromatic heterocyclic compound, and pharmaceutical composition and use thereof

#920 ✅ Patent 11,331,315 granted on 2022-05-17
US20220088009A1
Human necessities

Aripiprazole oral soluble film

#921
US20220088010A1
Human necessities

Co-Administration of inhibitors to produce insulin producing gut cells

#922
US20220088011A1
Human necessities

THERAPEUTIC AGENT FOR A TUMOR COMPRISING AN IDO INHIBITOR ADMINISTERED IN COMBINATION WITH AN ANTIBODY

#923 ✅ Patent 11,918,575 granted on 2024-03-05
US20220088012A1
Human necessities

PZA and cytochrome Bc1 inhibitor combination treatment

#924 ✅ Patent 11,654,143 granted on 2023-05-23
US20220088013A1
Human necessities

Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor, a JAK-2 inhibitor, and/or a BCL-2 inhibitor

#925
US20220088014A1
Human necessities

METHODS OF TREATING ADDICTION

#926
US20220088015A1
Human necessities

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF AGE-RELATED CARDIOMETABOLIC DISEASES

#927
US20220088016A1
Human necessities

CANCER TREATMENT USING MULTI-TARGETED KINASE INHIBITOR IN COMBINATION OF PROTEIN KINASE BIOMARKERS

#928
US20220088017A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS

#929 ✅ Patent 11,938,134 granted on 2024-03-26
US20220088018A1
Human necessities

Metalloenzyme inhibitor compounds

#930 ✅ Patent 12,336,992 granted on 2025-06-24
US20220088019A1
Human necessities

PAC-1 COMBINATION THERAPY

#931
US20220088020A1
Human necessities

TREATMENT OF ALOPECIA AREATA

#932
US20220088021A1
Human necessities

METHODS OF DIAGNOSING AND TREATING CANCER

#933 ✅ Patent 11,738,028 granted on 2023-08-29
US20220088022A1
Human necessities

Therapeutic regimen

#934
US20220088023A1
Human necessities

ANTIDIABETIC MEDICATIONS

#935
US20220088024A1
Human necessities

METHODS FOR TREATING CANCER USING TOZADENANT

#936
US20220088025A1
Human necessities

FUSED THIOPHENE COMPOUNDS

#937
US20220088026A1
Human necessities

METHODS OF TREATING TYROSINE KINASE INHIBITOR-INDUCED DIARRHEA

#938 ✅ Patent 11,433,078 granted on 2022-09-06
US20220088027A1
Human necessities

Pharmaceutical compositions comprising meloxicam

#939 ✅ Patent 11,918,588 granted on 2024-03-05
US20220088028A1
Human necessities

Neuronal nicotinic acetylcholine receptor partial agonists as therapeutics for chronic tinnitus

#940
US20220088029A1
Human necessities

COMBINATION THERAPY OF TETRACYCLIC QUINOLONE ANALOGS FOR TREATING CANCER

#941 ✅ Patent 11,826,373 granted on 2023-11-28
US20220088030A1
Human necessities

Methods for treatment of diseases

#942
US20220088031A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING RESISTANT AND RECURRENT FORMS OF CANCER

#943 ✅ Patent 11,806,356 granted on 2023-11-07
US20220088032A1
Human necessities

Compositions and uses thereof for treatment of idiopathic preterm birth

#944
US20220088033A1
Human necessities

METHODS FOR TREATING OR PREVENTING CANCER IN A KRAS-VARIANT PATIENT AND FOR DIAGNOSING RISK OF DEVELOPING MULTIPLE PRIMARY BREAST TUMORS

#945
US20220088034A1
Human necessities

METHODS OF TREATING TESTOSTERONE DEFICIENCY

#946 ✅ Patent 11,524,014 granted on 2022-12-13
US20220088035A1
Human necessities

Pharmaceutical formulations and systems for delivery of an androgenic agent and an aromatase inhibitor with sustained multi-phasic release profiles and methods of use

#947 ✅ Patent 11,969,435 granted on 2024-04-30
US20220088036A1
Human necessities

Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors

#948
US20220088037A1
Human necessities

A SUSTAINED RELEASE COMPOSITION COMPRISING A HYDROXYALKYL METHYLCELLULOSE

#949 ✅ Patent 11,752,160 granted on 2023-09-12
US20220088038A1
Human necessities

Method for reducing fat by administering benzenesulfonamide compositions

#950
US20220088039A1
Human necessities

METHODS OF MEDICAL TREATMENT WITH SUR1-TRPM4 CHANNEL INHIBITORS

#951
US20220088040A1
Human necessities

Use of System XC-Inhibitor for Treating Statin-Induced Myalgia

#952 ✅ Patent 11,564,935 granted on 2023-01-31
US20220088041A1
Human necessities

Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybin

#953
US20220088042A1
Human necessities

COMBINATION THERAPY INCLUDING SAPC-DOPS FOR THE TREATMENT OF PANCREATIC CANCER

#954 ✅ Patent 11,980,633 granted on 2024-05-14
US20220088043A1
Human necessities

Method for treating cancer using a combination of DNA-damaging agents and DNA-PK inhibitors

#955
US20220088044A1
Human necessities

SUBSTANCES FOR TREATMENT OF CORONAVIRUS INFECTION

#956
US20220088045A1
Human necessities

Treatment compositions

#957 ✅ Patent 11,957,697 granted on 2024-04-16
US20220088046A1
Human necessities

Viral receptor bound with sialic acid compounds

#958 ✅ Patent 12,303,523 granted on 2025-05-20
US20220088047A1
Human necessities

Method for treating dupuytren's disease

#959
US20220088048A1
Human necessities

USE OF SOTAGLIFLOZIN FOR THE TREATMENT OF PATIENTS WITH TYPE 1 DIABETES MELLITUS

#960
US20220088049A1
Human necessities

COMPOSITIONS, METHODS, AND KITS FOR DELIVERY OF POLYRIBONUCLEOTIDES

#961
US20220088050A1
Human necessities

TREATMENT OF FATTY LIVER DISEASE

#962
US20220088051A1
Human necessities

DOUBLE-STRANDED OLIGONUCLEOTIDE TARGETING DKK1 GENE, CONSTRUCT INCLUDING SAME, AND HAIR LOSS PREVENTION OR HAIR GROWTH COMPOSITION CONTAINING SAME

#963
US20220088052A1
Human necessities

TFAP2 INHIBITION FOR TREATING CARDIAC DISEASE INVOLVING FIBRO-FATTY REPLACEMENT

#964 ✅ Patent 12,109,224 granted on 2024-10-08
US20220088053A1
Human necessities

USB1 directed regulation of miRNAs related hematopoietic differentiation and affected in multiple forms of leukemia

#965
US20220088054A1
Human necessities

IMMUNE MODULATION WITH TLR9 AGONISTS FOR CANCER TREATMENT

#966 ✅ Patent 11,944,636 granted on 2024-04-02
US20220088055A1
Human necessities

Medicinal composition comprising a non-coding RNA molecule and an antibody targeting a tumor antigen

#967
US20220088056A1
Human necessities

COMBINATION FOR TREATING CANCER

#968
US20220088057A1
Human necessities

THERAPEUTIC AGENT FOR FIBROSIS

#969
US20220088058A1
Human necessities

ANTISENSE OLIGOMERS FOR TREATMENT OF AUTOSOMAL DOMINANT MENTAL RETARDATION-5 AND DRAVET SYNDROME

#970
US20220088059A1
Human necessities

COMBINED SPHERICAL NUCLEIC ACID AND CHECKPOINT INHIBITOR FOR ANTITUMOR THERAPY

#971 ✅ Patent 12,133,861 granted on 2024-11-05
US20220088060A1
Human necessities

Nail compositions having antifungal properties

#972
US20220088061A1
Human necessities

COSMETIC/DERMATOLOGICAL COMPOSITION

#973 ✅ Patent 11,484,548 granted on 2022-11-01
US20220088062A1
Human necessities

Substituted phenyl boronic acid containing polymers and methods of use

#974 ✅ Patent 11,576,928 granted on 2023-02-14
US20220088063A1
Human necessities

Substituted phenyl boronic acid containing polymers and methods of use

#975
US20220088064A1
Human necessities

DRUG AND PRODUCTION METHOD THEREFOR

#976 ✅ Patent 11,986,493 granted on 2024-05-21
US20220088065A1
Human necessities

Inorganic nitrite to improve cardiopulmonary hemodynamics

#977 ✅ Patent 11,998,564 granted on 2024-06-04
US20220088066A1
Human necessities

Stable cardioplegic solution for cardiac surgery

#978
US20220088067A1
Human necessities

PREVENTION OF INFECTION BY HIGHLY PATHOGENIC VIRUSES USING TOPICAL APPLICATION OF POVIDONE-IODINE ON MUCOUS MEMBRANES

#979
US20220088068A1
Human necessities

CATALYTIC SYSTEMS INCLUDING A PEROXIDE FOR DELIVERY OF OXYGEN TO SKIN AND RELATED METHODS OF USE

#980
US20220088069A1
Human necessities

TREATMENT OF NSCLC PATIENTS REFRACTORY FOR ANTI-PD-1 ANTIBODY

#981
US20220088070A1
Human necessities

METHODS FOR TREATMENT USING ADOPTIVE CELL THERAPY

#982
US20220088071A1
Human necessities

A BW6 Specific CAR Designed To Protect Transplanted Tissue From Rejection

#983
US20220088072A1
Human necessities

TREATMENT METHOD FOR PSORIASIS

#984
US20220088073A1
Human necessities

CHIMERIC ANTIGEN RECEPTORS WITH ENHANCED TUMOR INFILTRATION

#985
US20220088074A1
Human necessities

GENETICALLY MODIFIED GAMMA DELTA T CELLS AND METHODS OF MAKING AND USING

#986
US20220088075A1
Human necessities

COMBINATION THERAPIES OF EGFRVIII CHIMERIC ANTIGEN RECEPTORS AND PD-1 INHIBITORS

#987
US20220088076A1
Human necessities

Therapeutic Cell Systems and Methods for Treating Cancer and Infectious Diseases

#988 ✅ Patent 11,679,130 granted on 2023-06-20
US20220088077A1
Human necessities

Genetically engineered t cells with Regnase-1 and/or TGFBRII disruption have improved functionality and persistence

#989 ✅ Patent 11,679,131 granted on 2023-06-20
US20220088078A1
Human necessities

Genetically engineered T cells with regnase-1 and/or TGFBRII disruption have improved functionality and persistence

#990
US20220088079A1
Human necessities

METABOLITE ENCAPSULATING NANOPARTICLES TO ENHANCE CELLULAR CANCER IMMUNOTHERAPY

#991 ✅ Patent 11,344,581 granted on 2022-05-31
US20220088080A1
Human necessities

Restimulation of cryopreserved tumor infiltrating lymphocytes

#992 ✅ Patent 11,351,199 granted on 2022-06-07
US20220088081A1
Human necessities

Restimulation of cryopreserved tumor infiltrating lymphocytes

#993
US20220088082A1
Human necessities

Compositions and Method for Treating Primary Sclerosing Cholangitis and Related Disorders

#994
US20220088083A1
Human necessities

COMPOSITION FOR USE IN TREATING DYSTROPHIC EPIDERMOLYSIS BULLOSA

#995
US20220088084A1
Human necessities

USES OF MESENCHYMAL STEM CELLS

#996
US20220088085A1
Human necessities

COMPOSITION FOR TREATING BLOOD COAGULATION AND/OR COMPLEMENT DISORDERS

#997
US20220088086A1
Human necessities

Personalized Immunotherapies for Reduction of Brain Inflammation and Suicide Prevention

#998 ✅ Patent 12,036,245 granted on 2024-07-16
US20220088087A1
Human necessities

Pharmaceutical composition and cosmetic composition

#999
US20220088088A1
Human necessities

COMPOSITIONS COMPRISING BACTERIAL STRAINS

#1000
US20220088089A1
Human necessities

METHODS FOR TREATING AUTISM SPECTRUM DISORDER AND ASSOCIATED SYMPTOMS

#1001 ✅ Patent 11,351,205 granted on 2022-06-07
US20220088090A1
Human necessities

Microbiome related immunotherapies

#1002 ✅ Patent 12,329,788 granted on 2025-06-17
US20220088091A1
Human necessities

SYNBIOTIC COMPOSITIONS

#1003
US20220088092A1
Human necessities

COMPOSITIONS AND METHODS FOR INCREASING THE VIABILITY OF FREEZE-DRIED PROBIOTICS

#1004 ✅ Patent 11,771,725 granted on 2023-10-03
US20220088093A1
Human necessities

having various functions, and use thereof

#1005
US20220088094A1
Human necessities

PROBIOTIC COMPOSITIONS COMPRISING LACTOBACILLUS REUTERI STRAINS AND METHODS OF USE

#1006 ✅ Patent 11,793,842 granted on 2023-10-24
US20220088095A1
Human necessities

Method for reducing inflammation of chondrocytes caused by uric acid crystals using TCI227

#1007
US20220088096A1
Human necessities

ONCOLYTIC MYXOMA VIRUS EXPRESSING FAST P14 TO TREAT HEMATOLOGICAL CANCER

#1008 ✅ Patent 12,357,664 granted on 2025-07-15
US20220088097A1
Human necessities

OPTIMIZED ONCOLYTIC VIRUSES AND USES THEREOF

#1009
US20220088098A1
Human necessities

OPTIMIZED ONCOLYTIC VIRUSES AND USES THEREOF

#1010
US20220088099A1
Human necessities

METHOD FOR EXTRACTION OF AN AGENT FROM A PLANT SOURCE

#1011
US20220088100A1
Human necessities

COSMETIC, PHARMACEUTICAL AND NUTRACEUTICAL USE OF AN EXTRACT DERIVED FROM CANNABISSATIVA CELL CULTURES

#1012 ✅ Patent 11,980,304 granted on 2024-05-14
US20220088101A1
Human necessities

Method of drying botanicals

#1013
US20220088102A1
Human necessities

CROTON LECHLERI COMPOSITIONS AND THEIR USE IN THE TREATMENT OF CYSTIC FIBROSIS

#1014
US20220088103A1
Human necessities

PEANUT STEM AND LEAF EXTRACT AND PREPARATION METHOD AND USE THEREOF

#1015 ✅ Patent 11,622,986 granted on 2023-04-11
US20220088104A1
Human necessities

Moisturizing gel for preventing or healing injured nipples or areola in my mammalian females

#1016
US20220088105A1
Human necessities

METHOD AGAINST CORONAVIRUS INFECTION WITH WATER-EXTRACTED PRODUCT OF PERILLA FRUTESCENS

#1017
US20220088106A1
Human necessities

COMPOSITION COMPRISING CUDRANIA TRICUSPIDATE AS EFFECTIVE COMPONENT FOR ALLEVIATING, TREATING, OR PREVENTING MUSCULAR DISEASES, OR IMPROVING MUSCULE FUNCTIONS

#1018
US20220088107A1
Human necessities

METHOD FOR TREATING OR PREVENTING INFLAMMATION

#1019 ✅ Patent 11,576,943 granted on 2023-02-14
US20220088108A1
Human necessities

Functional food composition having cranial nerve protection effect and blood flow improvement effect

#1020 ✅ Patent 12,357,668 granted on 2025-07-15
US20220088109A1
Human necessities

Anticancer Activity of Buddleja Saligna Compositions

#1021 ✅ Patent 12,076,361 granted on 2024-09-03
US20220088110A1
Human necessities

Compositions with agents for mitigating methanogenesis in animals and related methods

#1022
US20220088111A1
Human necessities

PEPTIDE AND USE THEREOF

#1023 ✅ Patent 11,497,787 granted on 2022-11-15
US20220088112A1
Human necessities

Functionalized poly-ADP-ribose polymers for drug delivery

#1024
US20220088113A1
Human necessities

SPECIFIC PEPTIDE CLATHRIN INHIBITORS

#1025 ✅ Patent 11,607,440 granted on 2023-03-21
US20220088114A1
Human necessities

Methods of treating female infertility

#1026
US20220088115A1
Human necessities

PHARMACEUTICAL COMPOSITION, COMPRISING INHIBITORY PEPTIDE AGAINST FAS SIGNALING, FOR PREVENTION OR TREATMENT OF OBESITY, FATTY LIVER, OR STEATOHEPATITIS

#1027
US20220088116A1
Human necessities

Tyrosine Inhibitors with Immunosuppressive Activity in Human Neonatal Keratinocyte Progenitors

#1028 ✅ Patent 12,029,777 granted on 2024-07-09
US20220088117A1
Human necessities

Serine proteinase inhibitors: Serp-1 and Serp-1 RCL-derived peptides effect on microbiome composition and uses thereof

#1029
US20220088118A1
Human necessities

BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR CAIX

#1030
US20220088119A1
Human necessities

THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF DRY EYE DISEASE

#1031
US20220088120A1
Human necessities

CBM USES

#1032
US20220088121A1
Human necessities

COMPOSITIONS CONTAINING A PEPTIDE ABLE TO STIMULATE THE GPRC6A-DEPENDENT SIGNALING PATHWAY

#1033 ✅ Patent 12,303,547 granted on 2025-05-20
US20220088122A1
Human necessities

Compound, use, pharmaceutical composition, method of diagnosis, method of treatment, and method of transportation and/or internalization of a compound into eukaryotic cells

#1034 ✅ Patent 11,925,675 granted on 2024-03-12
US20220088123A1
Human necessities

Systemic delivery of adeno-associated virus vector expressing gamma-sarcoglycan and the treatment of muscular dystrophy

#1035
US20220088124A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING NECROTIZING ENTEROCOLITIS

#1036 ✅ Patent 12,070,487 granted on 2024-08-27
US20220088125A1
Human necessities

Pharmaceutical composition comprising PIBF protein as active ingredient for prevention or treatment of inflammatory disease

#1037
US20220088126A1
Human necessities

PHARMACEUTICAL COMPOSITION COMPRISING RUNX3 GENE OR PROTEIN AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF K-RAS MUTANT LUNG CANCER

#1038
US20220088127A1
Human necessities

TARGETING THE BAG FAMILY FOR THE TREATMENT OF NEURODEGENERATIVE DISEASE

#1039 ✅ Patent 11,433,118 granted on 2022-09-06
US20220088128A1
Human necessities

Long-acting VEGF inhibitors for intraocular neovascularization

#1040 ✅ Patent 11,382,955 granted on 2022-07-12
US20220088129A1
Human necessities

Long-acting VEGF inhibitors for intraocular neovascularization

#1041
US20220088130A1
Human necessities

COMPOUNDS AND METHODS FOR TREATING LIVER DISEASES

#1042
US20220088131A1
Human necessities

COMPOSITIONS AND METHODS RELATING TO C5L2

#1043
US20220088132A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING CHRONIC LUNG DISEASES

#1044
US20220088133A1
Human necessities

Nanoliposome Compositions And Methods Of Treating Stroke

#1045
US20220088134A1
Human necessities

CD200AR LIGANDS FOR CANCER IMMUNOTHERAPY

#1046
US20220088135A1
Human necessities

METHODS OF MAKING AND USING SOLUBLE MHC MOLECULES

#1047
US20220088136A1
Human necessities

NERVE GROWTH FACTOR MUTANT

#1048
US20220088137A1
Human necessities

METHODS FOR DETECTING AND MODULATING THE EMBRYONIC-FETAL TRANSITION IN MAMMALIAN SPECIES

#1049
US20220088138A1
Human necessities

METHODS FOR DETECTING AND MODULATING THE EMBRYONIC-FETAL TRANSITION IN MAMMALIAN SPECIES

#1050
US20220088139A1
Human necessities

NERVE GROWTH FACTOR MUTANT

#1051
US20220088140A1
Human necessities

Methods of Using Compositions Comprising Variants and Fusions of FGF19 Polypeptides for Treatment of Metabolic Disorders and Diseases

#1052
US20220088141A1
Human necessities

LYMPHANGIOGENESIS-PROMOTING AGENTS

#1053 ✅ Patent 11,857,599 granted on 2024-01-02
US20220088142A1
Human necessities

Compositions and methods for treating spinal muscular atrophy

#1054
US20220088143A1
Human necessities

ANGIOGENIC CONDITIONING TO ENHANCE CARDIAC CELLULAR REPROGRAMMING OF FIBROBLASTS OF THE INFARCTED MYOCARDIUM

#1055
US20220088144A1
Human necessities

SGLT-2 INHIBITORS OR IL-1R ANTAGONISTS FOR REDUCTION OF HYPOGLYCAEMIA AFTER BARIATRIC SURGERY

#1056 ✅ Patent 12,350,317 granted on 2025-07-08
US20220088145A1
Human necessities

IMMUNOTHERAPY FOR THE TREATMENT AND PREVENTION OF INFLAMMATORY BOWEL DISEASE

#1057
US20220088146A1
Human necessities

Melanocortin Receptor-Specific Peptide Formulations and Methods for Gastrointestinal Tract-Specific Delivery

#1058 ✅ Patent 12,303,553 granted on 2025-05-20
US20220088147A1
Human necessities

Long-acting growth hormone dosage forms with superior efficacy to daily somatropin

#1059
US20220088148A1
Human necessities

A PHARMACEUTICAL COMPOSITION COMPRISING INSULIN AND TRIGONAL GLUCAGON/GLP-1/GIP RECEPTOR AGONIST

#1060
US20220088149A1
Human necessities

Liquid Pharmaceutical Formulations of PTH Conjugates

#1061
US20220088150A1
Human necessities

Octreotide Microsphere-Based Arterial Embolization for Treating Obesity

#1062 ✅ Patent 12,220,447 granted on 2025-02-11
US20220088151A1
Human necessities

Proteolytic enzyme composition

#1063 ✅ Patent 11,717,560 granted on 2023-08-08
US20220088152A1
Human necessities

Compositions comprising nucleic acid molecules and methods of treating ATPase-mediated diseases

#1064
US20220088153A1
Human necessities

PHARMACEUTICAL COMPOSITION USING ENDOGENOUS CELLS FOR PREVENTING OR TREATING MUSCULOSKELETAL DISORDERS

#1065 ✅ Patent 12,144,846 granted on 2024-11-19
US20220088154A1
Human necessities

Strain for producing nattokinase and production method therefor

#1066
US20220088155A1
Human necessities

SUBCONJUNCTIVAL CHEMOTHERAPEUTIC DELIVERY BY FIBRIN SEALANT IN THE TREATMENT OF RETINOBLASTOMA

#1067
US20220088156A1
Human necessities

STABILIZED THROMBIN

#1068
US20220088157A1
Human necessities

METHODS FOR TREATING HEADACHE

#1069
US20220088158A1
Human necessities

METHOD OF AMELIORATING A PRO-INFLAMMATORY IMMUNOPHENOTYPE IN FARBER DISEASE SUBJECTS BY REPEATED ADMINISTRATION OF A RECOMBINANT HUMAN ACID CERAMIDASE

#1070 ✅ Patent 11,980,658 granted on 2024-05-14
US20220088159A1
Human necessities

Immunotherapeutic molecules and uses thereof

#1071
US20220088160A1
Human necessities

SEA LICE ANTIGENS AND VACCINES

#1072 ✅ Patent 12,178,864 granted on 2024-12-31
US20220088161A1
Human necessities

Trypanosomal vaccine

#1073
US20220088162A1
Human necessities

Heterologous Prime Boost Vaccine

#1074 ✅ Patent 12,215,341 granted on 2025-02-04
US20220088163A1
Human necessities

Hybrid immolative cell-penetrating complexes for nucleic acid delivery

#1075 ✅ Patent 12,312,391 granted on 2025-05-27
US20220088164A1
Human necessities

Anti-mutated KRAS T cell receptors

#1076 ✅ Patent 12,233,118 granted on 2025-02-25
US20220088165A1
Human necessities

Multivalent vaccine compositions and uses thereof

#1077
US20220088166A1
Human necessities

Modulation of Immunity to Drug Resistant and Latent MTB

#1078
US20220088167A1
Human necessities

VACCINE COMPOSITION FOR PREVENTING TUBERCULOSIS, COMPRISING GLYCOSYLATED AG85A PROTEIN AND METHOD FOR PREPARING SAME

#1079 ✅ Patent 11,904,008 granted on 2024-02-20
US20220088168A1
Human necessities

Preparation of live vaccines

#1080
US20220088169A1
Human necessities

VIRUS VACCINE

#1081 ✅ Patent 11,918,639 granted on 2024-03-05
US20220088170A1
Human necessities

Methods and compositions for inducing protective immunity against filovirus infection

#1082
US20220088171A1
Human necessities

IMMUNOGENIC COMPOSITIONS AND USES THEREOF

#1083 ✅ Patent 11,723,970 granted on 2023-08-15
US20220088172A1
Human necessities

Poxvirus vectors encoding HIV antigens, and methods of use thereof

#1084 ✅ Patent 11,865,171 granted on 2024-01-09
US20220088173A1
Human necessities

Foot-and-mouth disease vaccine

#1085
US20220088174A1
Human necessities

GENOMIC VARIANTS IN IG GENE REGIONS AND USES OF SAME

#1086
US20220088175A1
Human necessities

OPTIMIZED VACCINE COMPOSITIONS AND METHODS FOR MAKING THE SAME

#1087
US20220088176A1
Human necessities

ADJUVANTED NANOPARTICULATE INFLUENZA VACCINE

#1088
US20220088177A1
Human necessities

RETROVIRAL VECTOR FOR THE ADMINISTRATION AND EXPRESSION OF REPLICON RNA EXPRESSING HETEROLOGOUS NUCLEIC ACIDS

#1089 ✅ Patent 11,918,642 granted on 2024-03-05
US20220088178A1
Human necessities

HIV vaccination compositions comprising vaccinia VLPS and plant-produced VLPS presenting HIV antigens

#1090 ✅ Patent 12,005,113 granted on 2024-06-11
US20220088179A1
Human necessities

Porcine epidemic diarrhea virus strains and immunogenic compositions therefrom

#1091
US20220088180A1
Human necessities

IMMUNOGENIC COMPOSITIONS AND USE THEREOF

#1092
US20220088181A1
Human necessities

VIRUS SPECIFIC CYTOKINE-INDUCED KILLER CELLS

#1093 ✅ Patent 11,707,517 granted on 2023-07-25
US20220088182A1
Human necessities

Antigen specific immunotherapy for COVID-19 fusion proteins and methods of use

#1094
US20220088183A1
Human necessities

CHIMERIC ONCOLYTIC HERPESVIRUS THAT STIMULATES AN ANTITUMOR IMMUNE RESPONSE

#1095 ✅ Patent 11,857,622 granted on 2024-01-02
US20220088184A1
Human necessities

Human cytomegalovirus GB polypeptide

#1096
US20220088185A1
Human necessities

PASSIVE TRANSFER OF IMMUNITY USING RECOMBINANT HERPES SIMPLEX VIRUS 2 (HSV-2) VACCINE VECTORS

#1097
US20220088186A1
Human necessities

SAMRNA VACCINE AND PREPARATION METHOD THEREFOR

#1098 ✅ Patent 12,239,704 granted on 2025-03-04
US20220088187A1
Human necessities

Recombinant non-pathogenic Marek's disease virus constructs encoding multiple heterologous antigens

#1099
US20220088188A1
Human necessities

PHARMACEUTICAL PREPARATION FOR TREATING HEPATITIS B, PREPARATION METHOD THEREFOR AND USE THEREOF

#1100
US20220088189A1
Human necessities

IMMUNE MODULATION

#1101
US20220088190A1
Human necessities

Compositions and Methods for Targeting Mutant RAS

#1102 ✅ Patent 12,324,841 granted on 2025-06-10
US20220088191A1
Human necessities

METHODS OF TREATING CANCER WITH A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND AN ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATE

#1103 ✅ Patent 11,992,528 granted on 2024-05-28
US20220088192A1
Human necessities

Compositions and methods for conjugating activatable antibodies

#1104
US20220088193A1
Human necessities

Anti-CD55 Antibodies and Related Compositions and Methods

#1105
US20220088194A1
Human necessities

COMPOSITIONS COMPRISING ANTI-CD38 ANTIBODIES AND CARFILZOMIB

#1106
US20220088195A1
Human necessities

Prevention or mitigation of T-cell bispecific antibody-related adverse effects

#1107
US20220088196A1
Human necessities

Means and Methods for Treating Tumorous Diseases

#1108 ✅ Patent 12,194,095 granted on 2025-01-14
US20220088197A1
Human necessities

Combinations and uses thereof

#1109 ✅ Patent 11,642,410 granted on 2023-05-09
US20220088198A1
Human necessities

Targeting microbubbles

#1110
US20220088199A1
Human necessities

METHOD FOR PROTECTING GLYCEROL ALKYL ETHERS FROM OXIDATION

#1111 ✅ Patent 12,350,340 granted on 2025-07-08
US20220088200A1
Human necessities

VISCOSITY REDUCTION OF HIGHLY CONCENTRATED PROTEIN FORMULATIONS

#1112
US20220088201A1
Human necessities

LINEAR POLYSACCHARIDE BASED FILM PRODUCTS

#1113
US20220088202A1
Human necessities

Nucleic Acid-Drug Conjugate, Drug Delivery System, Preparation Method Therefor and Use Thereof

#1114 ✅ Patent 11,771,772 granted on 2023-10-03
US20220088203A1
Human necessities

Glycemic control using intrinsic factor bound to a vitamin Bconjugate of a glucagon-like peptide-1 receptor agonist

#1115
US20220088204A1
Human necessities

ANTICANCER DRUGS AND METHODS OF MAKING AND USING SAME

#1116 ✅ Patent 11,771,773 granted on 2023-10-03
US20220088205A1
Human necessities

Pharmaceutical preparation containing polyethylene gylcol loxenatide and preparation method thereof

#1117 ✅ Patent 12,083,182 granted on 2024-09-10
US20220088206A1
Human necessities

Controlled-release CNP agonists with increased NEP stability

#1118
US20220088207A1
Human necessities

BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR PD-L1

#1119
US20220088208A1
Human necessities

PHLIP®-MEDIATED INTRACELLULAR DELIVERY OF IMMUNO-STIMULATORY COMPOUNDS

#1120 ✅ Patent 11,628,221 granted on 2023-04-18
US20220088209A1
Human necessities

Peptide linker and combination for prodrugs activated by prostate-specific antigen

#1121 ✅ Patent 11,883,502 granted on 2024-01-30
US20220088210A1
Human necessities

Methods for production of capsular polysaccharide protein conjugates from serotype 19F

#1122 ✅ Patent 12,350,342 granted on 2025-07-08
US20220088211A1
Human necessities

O-LINKED GLYCOSYLATION RECOGNITION MOTIFS

#1123 ✅ Patent 12,214,050 granted on 2025-02-04
US20220088212A1
Human necessities

C-terminal lysine conjugated immunoglobulins

#1124
US20220088213A1
Human necessities

DRUG DELIVERY SYSTEM USING PH-DEPENDENT CELL-PENETRATING PEPTIDES, AND COMPOSITE THEREOF WITH DRUG

#1125
US20220088214A1
Human necessities

GLYCOENGINEERED ANTIBODY DRUG CONJUGATES

#1126
US20220088215A1
Human necessities

METHODS OF MAKING TARGETED VESICLES, AND COMPOSITIONS MADE THEREBY

#1127 ✅ Patent 12,029,794 granted on 2024-07-09
US20220088216A1
Human necessities

Virus-like particle conjugates for diagnosis and treatment of tumors

#1128 ✅ Patent 11,318,213 granted on 2022-05-03
US20220088217A1
Human necessities

Compositions and methods for delivery of RNA

#1129 ✅ Patent 12,201,695 granted on 2025-01-21
US20220088218A1
Human necessities

Polyglutamated pemetrexed and uses thereof

#1130 ✅ Patent 12,178,882 granted on 2024-12-31
US20220088219A1
Human necessities

Alpha polyglutamated pemetrexed and uses thereof

#1131 ✅ Patent 12,178,883 granted on 2024-12-31
US20220088220A1
Human necessities

Alpha and gamma-D polyglutamated pemetrexed antifolates and uses thereof

#1132
US20220088221A1
Human necessities

SELF-ASSEMBLED PEPTIDE NANOPARTICLE AND USE THEREOF

#1133
US20220088222A1
Human necessities

COMPOSITIONS AND METHODS FOR THE TREATMENT OF DEGENERATIVE OCULAR DISEASES

#1134
US20220088223A1
Human necessities

METHODS AND COMPOSITIONS FOR INCREASING SIALIC ACID PRODUCTION AND TREATING SIALIC RELATED DISEASE CONDITIONS

#1135
US20220088224A1
Human necessities

ARC-BASED CAPSIDS AND USES THEREOF

#1136
US20220088225A1
Human necessities

VIRAL TRANSDUCTION USING POLOXAMINES

#1137 ✅ Patent 12,329,828 granted on 2025-06-17
US20220088226A1
Human necessities

PYRIMIDINE NUCLEOSIDE COMPOUNDS FOR FLUORESCENCE IMAGING AND SPECTROSCOPY

#1138 ✅ Patent 11,590,245 granted on 2023-02-28
US20220088227A1
Human necessities

Method of detecting passively induced RF emissions from spin polarized electrons

#1139 ✅ Patent 11,654,204 granted on 2023-05-23
US20220088228A1
Human necessities

Rod-shaped plant virus nanoparticles as imaging agent platforms

#1140 ✅ Patent 12,070,513 granted on 2024-08-27
US20220088229A1
Human necessities

PSMA-binding agents and uses thereof

#1141 ✅ Patent 11,446,401 granted on 2022-09-20
US20220088230A1
Human necessities

Actinium-225 and checkpoint inhibitor combination therapy

#1142
US20220088231A1
Human necessities

RADIOIMMUNOCONJUGATES AND DNA DAMAGE AND REPAIR INHIBITOR COMBINATION THERAPY

#1143 ✅ Patent 12,263,234 granted on 2025-04-01
US20220088232A1
Human necessities

Anti-PD-L1 diabodies and the use thereof

#1144
US20220088233A1
Human necessities

Plasma Directed Electron Beam Wound Care System Apparatus and Method

#1145
US20220088234A1
Human necessities

AIR-EXCHANGING SANITATION APPARATUS AND METHOD

#1146 ✅ Patent 11,850,316 granted on 2023-12-26
US20220088235A1
Human necessities

Self-disinfecting photocatalyst sheet with primer

#1147 ✅ Patent 11,565,011 granted on 2023-01-31
US20220088236A1
Human necessities

Sterilizing media cassette

#1148 ✅ Patent 11,865,218 granted on 2024-01-09
US20220088237A1
Human necessities

Targeted approach for ultraviolet disinfection of surfaces

#1149
US20220088238A1
Human necessities

ULTRAVIOLET SANITIZATION UNIT FOR BEVERAGE CUPS

#1150
US20220088239A1
Human necessities

Germicidal UV Lamp Device

#1151
US20220088240A1
Human necessities

ULTRAVIOLET LIGHT DISINFECTING SYSTEMS

#1152
US20220088241A1
Human necessities

ROBOTIC, MOBILE APPARATUS FOR TREATING A ROOM, FOR EXAMPLE BY DISINFECTION

#1153 ✅ Patent 12,239,752 granted on 2025-03-04
US20220088242A1
Human necessities

Exposure and decontamination carousel

#1154 ✅ Patent 11,590,250 granted on 2023-02-28
US20220088243A1
Human necessities

Display device and sterilization device

#1155
US20220088244A1
Human necessities

UV LIGHT MONITORING SYSTEM FOR A UV DECONTAMINATION APPARATUS

#1156 ✅ Patent 12,076,454 granted on 2024-09-03
US20220088245A1
Human necessities

Disinfection behavior tracking and ranking

#1157 ✅ Patent 11,857,688 granted on 2024-01-02
US20220088246A1
Human necessities

Object decontamination apparatus and method

#1158
US20220088247A1
Human necessities

Open-Cell Foam Based Pathogen Remediation

#1159
US20220088248A1
Human necessities

IMPROVED METHOD AND COMPOSITIONS FOR SURFACE TREATMENT

#1160 ✅ Patent 12,005,834 granted on 2024-06-11
US20220088249A1
Human necessities

Autonomous seat sanitizing system for a vehicle

#1161
US20220088250A1
Human necessities

TRANSPORTATION DISINFECTION

#1162 ✅ Patent 12,364,781 granted on 2025-07-22
US20220088251A1
Human necessities

SYSTEMS AND METHODS FOR DEACTIVATION OF VIRUSES AND OTHER ORGANISMS WITH MOBILE ULTRAVIOLET LIGHT DEVICES

#1163 ✅ Patent 11,400,177 granted on 2022-08-02
US20220088252A1
Human necessities

Germicidal lighting

#1164 ✅ Patent 11,612,671 granted on 2023-03-28
US20220088253A1
Human necessities

Aroma diffuser

#1165 ✅ Patent 11,911,539 granted on 2024-02-27
US20220088254A1
Human necessities

Device for dispensing, in particular for vaporizing, volatile substances, in particular fragrances and/or active agents

#1166
US20220088255A1
Human necessities

SYSTEMS AND METHODS FOR SANITIZING AN INDOOR ENVIRONMENT

#1167
US20220088256A1
Human necessities

MISTING SYSTEM AND METHOD

#1168
US20220088257A1
Human necessities

ATOMIZATION DEVICE AND AROMA DIFFUSER

#1169 ✅ Patent 11,291,742 granted on 2022-04-05
US20220088258A1
Human necessities

Air stertilization lamp device

#1170
US20220088259A1
Human necessities

Device For Disinfecting Air With Electromagnetic Radiation

#1171 ✅ Patent 11,484,619 granted on 2022-11-01
US20220088260A1
Human necessities

Multi stage disinfecting air cleaner

#1172
US20220088261A1
Human necessities

SANITIZING SYSTEM FOR VEHICLE COMPARTMENT

#1173 ✅ Patent 11,786,628 granted on 2023-10-17
US20220088262A1
Human necessities

Air purifier

#1174
US20220088263A1
Human necessities

FAN FOR IMPROVING AIR QUALITY

#1175 ✅ Patent 12,144,906 granted on 2024-11-19
US20220088264A1
Human necessities

Bioadhesive hydrogels

#1176
US20220088265A1
Human necessities

BIOMATERIALS AND METHODS RELATED THERETO

#1177 ✅ Patent 12,121,626 granted on 2024-10-22
US20220088266A1
Human necessities

Blood coagulation-promoting silk fibroin-polypeptide electrospun membrane and preparation method thereof

#1178 ✅ Patent 11,833,268 granted on 2023-12-05
US20220088267A1
Human necessities

Implantable bodies comprising a regional composite

#1179 ✅ Patent 11,944,716 granted on 2024-04-02
US20220088268A1
Human necessities

Particulate coated hydrogel microparticles

#1180
US20220088269A1
Human necessities

METHOD OF DEHYDRATION OF EXTRACELLULAR MATRIX AND PARTICLES FORMED THEREFROM

#1181
US20220088270A1
Human necessities

Non-Uniformly Stiff Polymeric Scaffolds and Methods for Producing Thereof

#1182
US20220088271A1
Human necessities

METHODS FOR PREPARING TISSUE GRAFTS WITH ANTIMICROBIAL PROPERTIES

#1183
US20220088272A1
Human necessities

GRAFT AND USE THEREOF

#1184
US20220088273A1
Human necessities

Electrospun Cover Layer for Medical Implants

#1185
US20220088274A1
Human necessities

Targeted in Situ Therapeutic Delivery of Secreted Factors from Stem Cells for Treatment of Damaged Tissue

#1186
US20220088275A1
Human necessities

HYDROGELS, METHODS OF MAKING, AND METHODS OF USE

#1187 ✅ Patent 12,115,283 granted on 2024-10-15
US20220088276A1
Human necessities

Sustained-release injection formulation comprising conjugate of poly-L-lactic acid filler and hyaluronic acid filler and bioactive materials, and preparation method thereof

#1188
US20220088277A1
Human necessities

AN ECHOGENIC COATING FOR ULTRASOUND IMAGING OF MEDICAL DEVICES IN DEEP TISSUE LAYERS

#1189
US20220088278A1
Human necessities

Covered Stent For Local Drug Delivery

#1190 ✅ Patent 12,156,959 granted on 2024-12-03
US20220088279A1
Human necessities

Extracorporeal devices for methods for treating diseases associated with anti-neutrophil cytoplasmic antibodies

#1191 ✅ Patent 12,337,096 granted on 2025-06-24
US20220088280A1
Human necessities

BLOOD PURIFICATION DEVICE

#1192 ✅ Patent 12,102,745 granted on 2024-10-01
US20220088281A1
Human necessities

Blood purification device

#1193 ✅ Patent 12,239,773 granted on 2025-03-04
US20220088282A1
Human necessities

Bubble trap device

#1194
US20220088283A1
Human necessities

ENDOVASCULAR DEVICE FOR DYSFUNCTIONAL FISTULAS

#1195 ✅ Patent 12,343,466 granted on 2025-07-01
US20220088284A1
Human necessities

MULTIFUNCTIONAL CENTRAL SUCTION SYSTEM CAPABLE OF REMOTE MONITORING

#1196
US20220088285A1
Human necessities

SYSTEMS AND METHODS FOR APPLYING REDUCED PRESSURE THERAPY

#1197 ✅ Patent 12,082,997 granted on 2024-09-10
US20220088286A1
Human necessities

Removable and replaceable dressing interface for a negative-pressure therapy system

#1198
US20220088287A1
Human necessities

CONTACTLESS WOUND TREATMENT BARRIER AND METHOD OF CONTACTLESS WOUND TREATMENT

#1199
US20220088288A1
Human necessities

PIEZOELECTRIC PUMP ADAPTER FOR NEGATIVE-PRESSURE THERAPY

#1200 ✅ Patent 12,263,294 granted on 2025-04-01
US20220088289A1
Human necessities

SYSTEMS AND METHODS FOR OPERATING NEGATIVE PRESSURE WOUND THERAPY DEVICES